Gelatine Manufacturing Plant Project Report 2026: Cost Analysis, ROI, and Feasibility Insights

The benchmark plant capacity is 3,000 to 15,000 MT/year of edible and technical Gelatine. Pharmaceutical and capsule-grade units are often smaller, while large multi-source plants can exceed 20,000 MT/year.

The global gelatine market is currently valued at around USD 3.2 billion to USD 4.6 billion. It is projected to reach USD 4.8 billion to USD 6.7 billion by the early 2030s, growing at a CAGR of about 4.9% to 5.8%.

Main end-use segments include food and confectionery at 35% to 45%, pharmaceutical capsules and softgels at 25%-35%, and nutraceutical gummies and collagen blends at 10% to 15%. Technical, photographic, biomedical, and specialty uses represent the balance of demand.

Production technology includes raw material washing, degreasing, demineralization for bone, acid or alkaline conditioning, hot-water extraction, filtration, ion exchange, vacuum evaporation, sterilization, belt or drum drying, grinding, sieving, blending, and packing. The process follows collagen pretreatment and hot-water extraction, with extraction often occurring from about 50 to 95 degree Celsius.

Key ingredients include bovine hides, cattle bones, pigskins, fish skins or scales, hydrochloric acid, lime, sodium hydroxide, sulfuric acid, wash water, activated carbon, filter aid, ion-exchange resin, enzymes, packaging bags, and drums. These represent 55% to 70% of total raw material and utility expense.

The largest CAPEX component, including raw material handling, degreasing systems, acid or lime conditioning tanks, extraction vessels, filtration, evaporation, sterilization, drying, milling, and blending systems, represents 45 to 60% of the total gelatine plant setup cost.

Manufacturing costs are primarily driven by feedstock prices for bovine hides, cattle bones, pigskins, fish raw material, acids, lime, and utilities, which together represent 55% to 70% of total raw material and utility expense.

The major manufacturing and consumption regions are Europe, Asia-Pacific, North America, and South America. Europe accounts for approximately 41% of global gelatin market revenue, while Asia-Pacific represented about 26% and North America around 16%.

Available grades include food-grade 200 to 250 Bloom gelatine, as well as pharmaceutical, fish, and specialty capsule grades. Specifications depend on factors such as origin, bloom strength, ash, microbial limit, viscosity, and whether the product is Type A (acid treatment) or Type B (alkaline treatment).

Gelatine manufacturers need strong traceability and quality controls, particularly for animal origin and processing. Buyers may require Halal, Kosher, bovine, porcine, or fish-origin certification/declarations, depending on the intended market, while food and pharmaceutical grades must meet applicable microbiological, chemical, and pharmacopeial requirements.